[ CrossRef ] [ Google scholar ] [ PubMed ] McMurry R, Perdomo C, Liu G, Zhang S, Stevenson C, Campbell J, et al
Targeting caspase-1 has been shown to reduce cerebral edema and the incidence of hemorrhagic transformation (HT) during acute stroke [125]
Not medical advice
Bacteriostatic water: A sterile water solution that prevents bacterial growth, used for mixing with the peptide
References: Bo, Y., et al
Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules